Diabetes Core (Type 2)

Training clinical pharmacists to better manage Diabetes in GP Practices

Date: 30th May 2018

Cost: Free

Northern Ireland

Our interactive workshops will combine expert speakers and sharing of best practice by our clinical pharmacist facilitators who are conducting Type 2 Diabetes Mellitus related services in their own practices.

These meetings have been fully funded by Napp Pharmaceuticals Ltd.

The agenda was developed by Soar Beyond in conjunction with Napp Pharmaceuticals Ltd. Soar Beyond has paid the speaker honoraria on behalf of Napp Pharmaceuticals Ltd.

Speakers

Philip Newland-Jones

Philip Newland-Jones is a Consultant Pharmacist in Diabetes and Endocrinology and is the Clinical Director of the Diabetes and Endocrine service at University Hospitals Southampton NHS Foundation Trust. He is a member of the UKCPA Diabetes and Endocrinology Committee, the Joint British Diabetes Societies (JBDS-IP) Committee, and the Centre of Perioperative Care (CPOC) diabetes working group. At Southampton he is the clinical lead for type 1 diabetes and as an interest in severe insulin resistance.

Read Bio

Agenda

The workshop will focus on ‘insight’ in the morning and on ‘implementation’ the afternoon. The day has been structured to allow plenty of networking time and activities.

Afternoon (14:00 - 17:00)
The interactive sessions will cover:

Familiarisation with the use of practical tools and templates for practice pharmacists including clinical systems resources

Case Studies on helping practice pharmacists to manage change and effectively implement diabetes clinics using the i2i change resources and structure

Action planning on how you will implement back at your practice

Supported by

sponsor

PHGB/VOK/1016/0011c – Date of Preparation November 2016

This workshop is no longer available.

Health Care Professionals Attend An Event

Book onto an event as a healthcare professional
  • All communication will be received through this email.
  • This field is for validation purposes and should be left unchanged.